https://amplyx.com/wp-content/uploads/2019/11/logo.svg00eallisonhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgeallison2018-11-12 16:35:132020-02-26 10:50:30Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00eallisonhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgeallison2018-06-07 05:00:222020-02-26 14:18:54Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00eallisonhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgeallison2018-06-05 05:12:532020-02-26 14:20:44Amplyx Pharmaceuticals to Participate in BIO International Convention Panel and Present at Jefferies Global Healthcare Conference
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00eallisonhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgeallison2018-04-30 11:33:562020-02-26 14:21:48Amplyx Pharmaceuticals Demonstrates APX001 has Potent Activity Against Deadly Multidrug-Resistant Candida Species
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00adminhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgadmin2018-03-19 08:45:312020-02-26 14:22:31Amplyx Pharmaceuticals Receives Fourth "Qualified Infectious Disease Product" (QIDP) Designation from the FDA for APX001
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00adminhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgadmin2018-01-08 05:06:192020-02-26 14:23:02Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the J.P. Morgan 36th Annual Healthcare Conference
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00adminhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgadmin2017-08-01 18:41:252020-02-26 14:24:13Amplyx Pharmaceuticals Raises $67 Million in Series C Financing
https://amplyx.com/wp-content/uploads/2019/11/logo.svg00adminhttps://amplyx.com/wp-content/uploads/2019/11/logo.svgadmin2017-01-05 09:42:122020-02-26 14:24:22Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and Chief Executive Officer
